comparemela.com

Ecole Polytechnique Fe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hydricity concept uses solar energy to produce power round-the-clock

AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AB2 Bio Appoints Dr Djordje Filipovic as Chief Commercial Officer AB2 BioDecember 16, 2020 GMT Will drive commercial strategy and execution of Tadekinig alfa, currently in Phase 3 Joins AB2 Bio from Novartis and has extensive commercial and strategic experience LAUSANNE, Switzerland, Dec. 16, 2020 (GLOBE NEWSWIRE) AB2 Bio Ltd., a Phase 3 clinical-stage biotech company developing innovative therapies for the treatment of severe systemic autoinflammatory diseases, today announced the appointment of Djordje Filipovic, PhD, as Chief Commercial Officer (CCO). Dr Filipovic has more than 20 years of experience as a pharmaceutical executive, covering functions in marketing, strategy, general management at local, regional and global levels as well as in research and development. In his role as CCO of AB2 Bio, Dr Filipovic will be a key member of the Executive Team, responsible for the com

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.